MIRA INFORM REPORT

 

 

Report Date :           

02.12.2011

 

IDENTIFICATION DETAILS

 

Name :

AL JABRY PHARMACY LLC

 

 

Registered Office :

Building No: 705, Al Emar Street, Mobella, Sanaya, P O Box  591, Seeb 121

 

 

Country :

Oman 

 

 

Financials (as on) :

31.12.2010

 

 

Date of Incorporation :

19.06.1979

 

 

Com. Reg. No.:

1/08748/7

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Wholesale and retail of pharmaceuticals

 

 

No. of Employees :

54 Persons

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

US$ 400,000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30th, 2011

 

Country Name

Previous Rating

                   (30.06.2011)                  

Current Rating

(30.09.2011)

Oman

a2

a2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

SUMMARY

 

Company Name                                     : AL JABRY PHARMACY LLC

Country of Origin                                    : Oman

Legal Form                                            : Limited Liability Company - LLC

Registration Date                                   : 19th June 1979

Commercial Registration Number                        : 1/08748/7

Chamber Membership Number                : 10787

Issued Capital                                        : RO 151,000

Paid up Capital                                      : RO 151,000

Total Workforce                                     : 54

Activities                                               : Wholesale and retail of pharmaceuticals.

Financial Condition                                 : Fair

Payments                                             : Nothing detrimental uncovered

Operating Trend                                     : Steady

Recommended Credit Limit                     : US$ 400,000

Person Interviewed                                 : Ahmer Manawar Hussain Khan, Director

 

COMPANY NAME

 

AL JABRY PHARMACY LLC

 

 

company ADDRESS

 

Registered & Physical Address

Location            : Building No: 705, Al Emar Street, Mobella, Sanaya

PO Box             : 591

Town                 : Seeb 121

Country             : Oman

Telephone         : (968) 24454312

Facsimile          : (968) 24454314

Mobile               : (968) 99383800 / 98282933

Email                : nadeempathan@gmail.com / ajpharma@omantel.net.om / ahmed@ajpharma.com

 

Premises

Subject operates from a medium sized suite of offices that are rented and located in the Central Business Area of Seeb.

 

Branches

 

     Location                                                                                          Description

 

·       Mawalleh                                                                                          Pharmacy

Seeb

Tel: (968) 24544824

 

·       Seeb Town                                                                                       Pharmacy

Seeb

     Tel: (968) 24420761

 

·       Ibra                                                                                                  Pharmacy

Tel: (968) 25570050

 

·       Fanja                                                                                               Pharmacy

Tel: (968) 25360549

 

 

KEY PRINCIPALS

 

     Name                                                                      Nationality       Position

 

·       Sulaiman Mohamed Al Jabry                                      Omani               Managing Director

 

·       Ahmed Sulaiman Mohamed Al Jabry                           Omani               Director

 

·       Khalil Sulaiman Mohamed Al Jabry                             Omani               Director

 

·       Manawar Hussain Khan                                             Indian                Director

 

·       Ahmer Manawar Hussain Khan                                   Indian                Director

 

·       Venkat Ramana                                                             -                  General Manager

 

·       S Shri Hari                                                                     -                  Logistics Manager

 

·       C S Raj Kumar                                                               -                  Regulatory Manager

 

 

LEGAL FORM & OWNERS

 

Date of Establishment  : 19th June 1979

 

History                         : Subject began in 1979 as a Sole Proprietorship but it re-registered as a Limited Liability

  Company in 2010.

 

Legal Form                  : Limited Liability Company - LLC

 

Commercial Reg. No.  : 1/08748/7

 

Chamber Member No. : 10787

 

Issued Capital              : RO 151,000

 

Paid up Capital            : RO 151,000

 

Name of Shareholder (s)

 

·       Sulaiman Mohamed Al Jabry

 

·       Ahmed Sulaiman Mohamed Al Jabry

 

·       Khalil Sulaiman Mohamed Al Jabry

 

·       Manawar Hussain Khan

 

·       Ahmer Manawar Hussain Khan

 

 

OPERATIONS

 

Activities: Engaged in the wholesale and retail of pharmaceuticals.

 

                 Subject specialises in pharmaceutical formulations, health products, surgical goods and hospital

     disposables, adult incontinence products, medical and hospital equipment and furniture, general and

     surgical instruments, laboratory products, dental and orthodontics, baby products and OTC products.

 

Import Countries: Germany, United Kingdom, Netherlands, Italy, Japan, China, Taiwan, India and Jordan.

 

International Suppliers:

 

·       Rotexmedica                        Germany

·       Dentaurum                            Germany

·       Cardiomed                            Germany

·       Nopa Instruments                  Germany

·       Diagramm Halbach                Germany

·       PSP Dental                          United Kingdom

·       Daniels Health Care               United Kingdom

·       Biosensors                           Netherlands

·       Dispotech                             Italy

·       Kawamoto                            Japan

·       Winner Medical                     China

·       Winsound Indus                    Taiwan

·       Kopran                                 India

·       Medicare                              India

·       IMPCO                                 Jordan

·       Specialized Medical              Jordan

 

Operating Trend: Steady

 

Subject has a workforce of 54 employees.

 

 

FINANCIAL DATA

 

Financial highlights provided by local sources are given below:

 

Currency: Riyal Omani (RO)

 

                                                Year Ending 31/12/09:                Year Ending 31/12/10:

 

Total Sales                                RO 2,695,000                            RO 2,950,000

 

Local sources consider subject’s financial condition to be Fair.

 

The above figures were provided by Mr Ahmer Manawar Hussain Khan, Director

 

 

BANKERS

 

·       Commercial Bank of Oman SAOG

Muttrah Business District

PO Box: 1696, Ruwi 112

Muscat

Tel: (968) 24793225 / 24793226 / 24793228

Fax: (968) 24793229

 

 

PAYMENT HISTORY

 

No complaints regarding subject’s payments have been reported.

 

 

GENERAL COMMENTS

 

Local sources report that payment obligations are met in a generally timely manner and the operating history is clear. As such the company is deemed a fair trade risk and the above credit figure is considered to be within subject’s financial means.

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.51.65

UK Pound

1

Rs.81.06

Euro

1

Rs.69.51

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.